Canada, January 18, 2020 (The CANNABIS INVESTOR)- State Marijuana Laws and the Federal Government’s Out-of-Date Policy Are Still Very Far Apart Washington DC Lawmakers Push the Trump Administration for Greater Cannabis Research Freedoms As of today in the United States, cannabis is legal in 33 states for medical purposes and …
Read More »
cannabis cultivation in a dark room, black background potted marijuana plant, medical cannabis TORONTO (January 17, 2020) – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”) is pleased to announce that Executive Co-Chairman and CEO Dr. Raza Bokhari, along with the founders, members of …
Read More »
Canada, January 9, 2020 (Proactive)- FSD Pharma (NASDAQ: HUGE-CSE: HUGE) Executive Co-Chairman and CEO Dr Raza Bokhari, joined Steve Darling from Proactive Vancouver to discuss the company listing on the Nasdaq stock exchange under ticker “HUGE” Dr Bokhari what this step means for the company. Dr Bokhari also told Proactive what the …
Read More »
Canada, January 14, 2020 (420 INTEL)- Cannabis 2.0 is coming soon to Canada — and one Alberta business hopes to be on the ground floor of this growing industry. “We’re trying to reduce the risk and eliminate the barriers of entry that many people are having trying to get into …
Read More »
Canada, January 12, 2020 (420 INTEL) – Flu season is in full swing and people are looking for relief wherever they can find it. CBD (cannabidiol) is often promoted as a way to diminish the symptoms of flu and common cold, but does it actually work? You always know when …
Read More »
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this As medical cannabis legislation expands globally; the green rush has pulled hundreds of entrepreneurs and businesses into the cultivation sector …
Read More »
UK, January 8, 2020 (OPEN ACCESS GOVERNMENT)- Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies The use of cannabinoids from Cannabis sativa L. in therapeutics involves various routes and forms of administration such as raw herbal …
Read More »
Canada, January 6, 2020 (420 INTEL)- As we enter a new year and a new decade, it’s exciting to predict where the cannabis industry will be in another ten years, and also to reflect on how far the industry as come. The legal industry has made incredible strides over the course …
Read More »
London, December 21, 2109 (INDEPENDET)- Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed. Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6 January. Hundreds of children will be among …
Read More »
A $1.4 trillion federal spending bill that passed both houses of Congress and was expected to be signed Friday by President Donald Trump reportedly includes provisions that would benefit hemp and CBD businesses. The Consolidated Appropriations Act of 2020 secures nearly $20 million in funding for the growing hemp industry, according to …
Read More »Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Investment value finders Investment value finders